Alex Thompson

Stock Analyst at Stifel

(0)
# 4916
Out of 5,370 analysts
45
Total ratings
30.00%
Success rate
-23.11%
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
CGEM Cullinan Therapeutic...
Reinstates: Buy
22
8.73 152% 1 Jun 11, 2025
KYMR Kymera Therapeutics
Reinstates: Buy
55
46.66 17.87% 1 May 20, 2025
TVTX Travere Therapeutics
Maintains: Hold
22 23
14.46 59.06% 3 May 2, 2025
THRD Third Harmonic Bio
Downgrades: Hold
23 5
5.42 -7.75% 2 Mar 28, 2025
AVTX Avalo Therapeutics
Initiates Coverage On: Buy
36
4.61 680.91% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
30.94 93.92% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
200 207
177.4 16.69% 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
49
n/a n/a 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 57
n/a n/a 4 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
485 500
544.81 -8.22% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
36 54
16.87 220.09% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
44
18.02 144.17% 1 Feb 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
6 2
2.17 -7.83% 5 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 69
42.51 62.31% 2 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.44 -30.56% 4 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
15.48 158.4% 2 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
7.97 3915.06% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 34
15.57 118.37% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
43 41
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
1.35 2344.44% 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
n/a n/a 1 Sep 7, 2022